Merck & Company (1MRKX) Stock Statistics & Valuation Metrics

Merck & Company has a market cap or net worth of EUR 326.78B. The enterprise value is EUR 404.16B.

Market Cap

EUR 326.78B

Enterprise Value

EUR 404.16B

Merck & Company has 2,465,245,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

2,465,245,600

Owned by Insiders

0.05%

Owned by Institutions

55.43%

Merck & Company’s return on equity (ROE) is 0.35 and return on invested capital (ROIC) is 18.27%.

Return on Equity (ROE)

0.35

Return on Assets (ROA)

0.13

Return on Invested Capital (ROIC)

18.27%

Return on Capital Employed (ROCE)

0.22

Revenue Per Employee

877.38K

Profits Per Employee

246.68K

Employee Count

74,000

Asset Turnover

0.47

Inventory Turnover

2.73

The current PE Ratio of Merck & Company is 151.07. Merck & Company’s PEG ratio is -1.74.

PE Ratio

151.07

PS Ratio

5.42

PB Ratio

8.17

Price to FCF

24.75

Price to Operating Cash Flow

19.62

PEG Ratio

-1.74

In the last 12 months, Merck & Company had revenue of 64.93B and earned 18.25B in profits. Earnings per share was 7.30.

Revenue

64.93B

Gross Profit

46.73B

Operating Income

23.49B

Pretax Income

21.07B

Net Income

18.25B

EBITDA

28.26B

Earnings Per Share (EPS)

7.30

In the last 12 months, operating cash flow was 18.70B and capital expenditures -3.96B, giving a free cash flow of 14.75B billion.

Operating Cash Flow

18.70B

Free Cash Flow

14.75B

Free Cash Flow per Share

5.95

Merck & Company pays an annual dividend of ―, resulting in a dividend yield of 2.25%

Dividend Per Share

―

Dividend Yield

2.25%

Payout Ratio

N/A

Free Cash Flow Yield

4.09%

Earnings Yield

0.68%

Beta

0.21

52-Week Price Change

75.15%

50-Day Moving Average

129.10

200-Day Moving Average

110.24

Relative Strength Index (RSI)

50.76

Average Volume (3m)

183

Merck & Company upcoming earnings date is Feb 02, 2027, Before Open (Not Confirmed).

Last Earnings Date

Oct 29, 2026

Next Earnings Date

Feb 02, 2027

Ex-Dividend Date

―

Merck & Company as a current ratio of 1.54, with Debt / Equity ratio of 96.06%

Current Ratio

1.54

Quick Ratio

1.30

Debt to Market Cap

0.19

Net Debt to EBITDA

1.27

Interest Coverage Ratio

17.31

In the past 12 months, Merck & Company has paid 2.80B in taxes.

Income Tax

2.80B

Effective Tax Rate

0.13

Merck & Company EV to EBITDA ratio is 31.06, with an EV/FCF ratio of 27.45.

EV to Sales

6.01

EV to EBITDA

31.06

EV to Free Cash Flow

27.45

EV to Operating Cash Flow

21.64

Merck & Company has EUR 9.65B in cash and marketable securities with EUR 53.78B in debt, giving a net cash position of -EUR 44.13B billion.

Cash & Marketable Securities

EUR 9.65B

Total Debt

EUR 53.78B

Net Cash

-EUR 44.13B

Net Cash Per Share

-EUR 17.90

Tangible Book Value Per Share

-EUR 0.60

Gross margin is 76.95%, with operating margin of 16.24%, and net profit margin of 3.64%.

Gross Margin

76.95%

Operating Margin

16.24%

Pretax Margin

7.08%

Net Profit Margin

3.64%

EBITDA Margin

19.37%

EBIT Margin

11.10%

The average price target for Merck & Company is EUR 144.47, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

EUR 144.47

Price Target Upside

10.42% Upside

Analyst Consensus

Moderate Buy

Analyst Count

22

Revenue Growth Forecast

0.11%

EPS Growth Forecast

-87.11%

Smart Score

7

AI Score

―